Teva Pharmaceutical Industries (TEVA) Cost of Revenue (2009 - 2026)
Teva Pharmaceutical Industries' Cost of Revenue came in at $1.96 billion for Q3 2026, down 10.2% from $2.18 billion a year earlier and down 1.7% from the prior quarter.
Powered by 
Analysis
Teva Pharmaceutical Industries (TEVA) Cost of Revenue (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Teva Pharmaceutical Industries reported Cost of Revenue of $8.01 billion, down 4.3% year-over-year; for FY2025, it came in at $8.32 billion, down 1.9% from FY2024.
- Cost of Revenue carries a five-year compound annual growth rate of -1.4% (FY2020 to FY2025).
- Going back by year, Cost of Revenue was $8.48 billion in FY2024 (+3.4%), $8.2 billion in FY2023 (+3.1%), $7.95 billion in FY2022 (-4.0%) and $8.28 billion in FY2021 (-7.3%).
- The Q3 2026 figure represents the lowest quarterly Cost of Revenue since Q3 2022.
- Year-over-year, Cost of Revenue has declined for seven consecutive quarters, with an average decline of 2.3% over the last eight quarters.
- The fastest year-over-year change in Cost of Revenue over five years came in Q3 2024 (growth of 9.2%), and the weakest in Q4 2021 (a decline of 14.8%).
- Business Quant data shows TEVA's Cost of Revenue at $1.99 billion (Q2 2026), $2.01 billion (Q1 2026) and $2.06 billion (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,251.13 Bn | 1,224.74 Bn | 20.46 Bn | 3.93 Bn |
| 2 | Johnson & Johnson | 677.29 Bn | 597.15 Bn | 17.30 Bn | 8.10 Bn |
| 3 | AbbVie | 518.44 Bn | 486.45 Bn | 13.12 Bn | 4.29 Bn |
| 4 | Merck | 364.56 Bn | 327.50 Bn | 13.19 Bn | 4.89 Bn |
| 5 | Novartis Ag | 316.19 Bn | 289.43 Bn | - | - |
| 6 | Astrazeneca | 293.21 Bn | 267.11 Bn | 13.26 Bn | 2.95 Bn |
| 7 | Amgen | 250.58 Bn | 202.23 Bn | 7.58 Bn | 2.79 Bn |
| 8 | Gilead Sciences | 210.08 Bn | 185.19 Bn | 6.73 Bn | 1.57 Bn |
| 9 | Pfizer | 167.84 Bn | 115.19 Bn | 12.56 Bn | 4.03 Bn |
| 10 | Teva Pharmaceutical Industries | 49.99 Bn | 34.96 Bn | 2.44 Bn | 1.96 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.96 Bn |
| Jun 30, 2026 | 1.99 Bn |
| Mar 31, 2026 | 2.01 Bn |
| Dec 31, 2025 | 2.06 Bn |
| Sep 30, 2025 | 2.18 Bn |
| Jun 30, 2025 | 2.07 Bn |
| Mar 31, 2025 | 2.01 Bn |
| Dec 31, 2024 | 2.11 Bn |
| Sep 30, 2024 | 2.18 Bn |
| Jun 30, 2024 | 2.14 Bn |
| Mar 31, 2024 | 2.05 Bn |
| Dec 31, 2023 | 2.04 Bn |
| Sep 30, 2023 | 2.00 Bn |
| Jun 30, 2023 | 2.08 Bn |
| Mar 31, 2023 | 2.08 Bn |
| Dec 31, 2022 | 2.11 Bn |
| Sep 30, 2022 | 1.93 Bn |
| Jun 30, 2022 | 1.99 Bn |
| Mar 31, 2022 | 1.92 Bn |
| Dec 31, 2021 | 2.05 Bn |
API Access
Teva Pharmaceutical Industries Cost of Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=TEVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cost-of-revenue", "ticker": "TEVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=TEVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();